BOSTON, Jan. 08, 2026 -- Aktis Oncology, Inc. (“Aktis”), a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large patient populations, including those not addressed...
Art Pappas will speak at the Personalized Medicine in North Carolina: Innovation to Application conference that will be held in Research Triangle Park, NC: "Investors Perspectives on Investments in Personalized Medicine"
News | 05. 11. 2009
